Skip to main content

Table 3 Pooled prevalence of radiological findings and treatment of pregnant women with coronavirus infection in the present systematic review and meta–analysis

From: The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal–fetal transmission: a systematic review and meta-analysis

Radiological finding and treatment of patients with CoV infection

Study (n)

Number of reports

Pregnancies (n)

Pooled % (95%-CI)

Radiological finding

 Unilateral pneumonia

2

3

15

20% [4.4–48.6]

 Bilateral pneumonia

6

11

19

57.9% [33.5–80.1]

 Ground-glass opacity

8

50

76

65.8% [54.2–76.4]

 Multiple patchy infiltrate

5

5

22

22.7% [8.9–45.2]

Treatment

 Oseltamivir

6

14

23

56.5% [35.1–64.3]

 Remdesivir

5

3

16

18.8% [13.8–29.1]

 Lopinavir

2

2

12

16.7% [13.1–41.1]

 Ritonavir

3

2

13

15.4% [10.1–31.7]

 Ganciclovir

7

2

10

20% [12.8–44.2]

 Ribavirin

11

15

23

65.2% [47.3–78.4]

 Other antiviral therapy

11

89

128

69.5% [39.2–77.8]

 Azithromycin

4

7

20

35% [22.3–48.5]

 Other antibiotic therapy

13

102

157

64.9% [60.9–73.1]

 Hydroxychloroquine

12

59

74

79.7% [70.1–89.3]

 Hydrocortisone

3

11

24

45.8% [37.2–59.6]

 Mechanical ventilation

7

23

127

18.1% [12.26.8]

 Oxygen therapy

9

89

113

78.8% [65.4–89.6]